Clinical Trial Update: HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention) [Phase 1]

View source ↗

Summary

Phase 1 pilot trial update at Yale University investigating polypharmacy in people with HIV and alcohol use, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Cannabis Use Disorder
• HIV Infection

Snippet

Sponsor: Yale University | Conditions: Hiv, Alcohol Drinking | Phase 1 | Status: RECRUITING